Literature DB >> 23573060

Use of implantable loop recorders to unravel the cause of unexplained syncope.

Aniket Puri1, Rohit Kumar Srivastava.   

Abstract

Syncope is a symptom of many underlying disease states, which range from the relatively benign to the life threatening. There are numerous investigations done for patients with recurrent unexplained syncope which may have very low yield when it comes to making a definitive diagnosis. Recently, the implantable loop recorder (ILR) for continuous monitoring of the cardiac rhythm has been launched in India. This review will briefly discuss these current available strategies and focus on the usefulness of an ILR in the definitive diagnosis and treatment of patients with a recurrent unexplained syncope.

Entities:  

Keywords:  Syncope; implantable loop recorder

Year:  2013        PMID: 23573060      PMCID: PMC3594900          DOI: 10.1016/s0972-6292(16)30606-4

Source DB:  PubMed          Journal:  Indian Pacing Electrophysiol J        ISSN: 0972-6292


  25 in total

1.  Electromagnetic interference of an implantable loop recorder by commonly encountered electronic devices.

Authors:  C C de Cock; H J Spruijt; L M van Campen; A W Plu; C A Visser
Journal:  Pacing Clin Electrophysiol       Date:  2000-10       Impact factor: 1.976

Review 2.  Congenital and acquired long QT syndrome.

Authors:  A J Camm; M J Janse; D M Roden; M R Rosen; J Cinca; S M Cobbe
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

3.  The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope.

Authors:  A D Krahn; G J Klein; R Yee; V Manda
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

4.  AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society.

Authors:  S Adam Strickberger; D Woodrow Benson; Italo Biaggioni; David J Callans; Mitchell I Cohen; Kenneth A Ellenbogen; Andrew E Epstein; Paul Friedman; Jeffrey Goldberger; Paul A Heidenreich; George J Klein; Bradley P Knight; Carlos A Morillo; Robert J Myerburg; Cathy A Sila
Journal:  J Am Coll Cardiol       Date:  2006-01-17       Impact factor: 24.094

5.  Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope.

Authors:  A Moya; M Brignole; C Menozzi; R Garcia-Civera; S Tognarini; L Mont; G Botto; F Giada; D Cornacchia
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

6.  Heart rhythm during syncope and presyncope: results of implantable loop recorders.

Authors:  P R Nierop; R van Mechelen; A van Elsäcker; R H Luijten; A Elhendy
Journal:  Pacing Clin Electrophysiol       Date:  2000-10       Impact factor: 1.976

7.  The clinical impact of implantable loop recorders in patients with syncope.

Authors:  David J Farwell; Nick Freemantle; Neil Sulke
Journal:  Eur Heart J       Date:  2005-11-28       Impact factor: 29.983

8.  Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test.

Authors:  R Sheldon; S Rose; P Flanagan; M L Koshman; S Killam
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

Review 9.  Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapy.

Authors:  D J Kosinski; B P Grubb
Journal:  Curr Opin Cardiol       Date:  1994-01       Impact factor: 2.161

10.  Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry.

Authors:  Nils Edvardsson; Viveka Frykman; Rob van Mechelen; Peter Mitro; Afsaneh Mohii-Oskarsson; Jean-Luc Pasquié; Hemanth Ramanna; Frank Schwertfeger; Rodolfo Ventura; Despina Voulgaraki; Claudio Garutti; Pelle Stolt; Nicholas J Linker
Journal:  Europace       Date:  2010-11-19       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.